Strategy

Lynn leads global teams as VP, Global Biologics Supply Chain at Bristol Myers Squibb since Dec 2022. In this capacity she is leading a transformation to deliver a highly synchronized, transparent, and predictable end-to-end Global Supply Chain. Her role is focused on balancing agility and efficiency while investing in capabilities to enable accelerated delivery of pipeline assets through our supply network.

Lynn joined BMS from Merck, where she had 20 years of global experience across manufacturing, supply chain, strategy, engineering and policy, across developed and developing markets. During her tenure she has worked across small molecule OSD, biologics and vaccines modalities. She has lived overseas in Asia for over eight years on assignment in Taiwan and Singapore. Lynn’s most recent role was Large Molecule Value Chain leader responsible for Established and Global Health Security Vaccine value chains (including pediatric, Ebola and COVID response). In this role she partnered with commercial, research and manufacturing colleagues to manage long-term sustainable supply strategy for these vaccines.

In the community she currently serves as a board member for alma mater- Cornell Engineering (CEAA) and most recently the US-Taiwan Business Council. She is active with ASCEND (Pan Asian Leaders). Mother of three active daughters and avid sports enthusiast, she has coached youth sports for many years attracted to the parallels of leadership through lessons learned on and off the field.